Coronavirus infection
1 paper
Trial sponsors
Company1 trialPhase 2/3525 people
National Vaccine and Serum Institute, China
Company1 trialPhase 21,800 people
Company1 trialPhase 218 people
Company1 trialPhase 140 people
1 trialPhase 4659 people
1 trialPhase 4414 people
Government of Punjab, Specialized Healthcare and Medical Education Department
1 trialPhase 4125 people
1 trialPhase 410 people